Phenotypes of organ involvement in sarcoidosis
暂无分享,去创建一个
J. Milanowski | A. Günther | M. Krawczak | A. Prasse | J. Strausz | V. Poletti | C. Grah | P. Zabel | E. Bargagli | P. Rottoli | B. Marshall | K. O'Reilly | S. Freitag-Wolf | M. Keane | W. Wuyts | B. Wallaert | P. Bresser | L. Spencer | C. Grohé | F. Bonella | A. Millar | S. Donnelly | R. Kieszko | J. Schupp | A. Fischer | L. Ho | D. Valeyre | U. Costabel | L. Tittmann | A. Jochens | Y. Kendrick | H. Wirtz | V. Kolek | M. Pfeifer | K. Gaede | R. Jonkers | M. Sterclova | M. Vašáková | J. Homolka | C. Olivieri | M. Petrek | S. Pabst | T. Peroš-Golubičić | Zamir Kadija | A. Crawshaw | S. O'Beirne | V. Mihailović-Vučinić | M. Luisetti | S. Schreiber | J. Müller‐Quernheim | A. Dubaniewicz | S. Haraldsdóttir | A. Slováková | S. Filipović | Aleksandar Grubanovic | K. B. Jorundsdottir | A. Müller | J. Schnerch | D. Jovanovic | Jelica Videnovic-Ivanovic | Anette Weihrich
[1] Y. Cozier. Assessing the worldwide epidemiology of sarcoidosis: challenges and future directions , 2016, European Respiratory Journal.
[2] D. Maucort-Boulch,et al. Sarcoidosis-related mortality in France: a multiple-cause-of-death analysis , 2016, European Respiratory Journal.
[3] J. Grunewald,et al. Sarcoidosis incidence and prevalence: a nationwide register-based assessment in Sweden , 2016, European Respiratory Journal.
[4] T. Fingerlin,et al. Genetics of Sarcoidosis. , 2015, Clinics in chest medicine.
[5] R. Baughman,et al. Clinical phenotypes in sarcoidosis , 2014, Current opinion in pulmonary medicine.
[6] A. Prasse,et al. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. , 2014, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[7] E. Horváth-Puhó,et al. Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort Study , 2013, The American Journal of Gastroenterology.
[8] D. Lackland,et al. The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States. , 2012, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[9] K. Golnik,et al. Neuro-ophthalmic sarcoidosis. , 2012, Eye and brain.
[10] P. Rosenstiel,et al. Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes , 2010, European Respiratory Journal.
[11] 陶仲为. Sarcoidosis , 2009 .
[12] S. Löfgren. Primary Pulmonary Sarcoidosis.1 , 2009 .
[13] S. Ratcliffe,et al. GEEQBOX: A MATLAB Toolbox for Generalized Estimating Equations and Quasi-Least Squares , 2008 .
[14] Sébastien Lê,et al. FactoMineR: An R Package for Multivariate Analysis , 2008 .
[15] S. Kudoh,et al. Epidemiology of sarcoidosis in Japan , 2008, European Respiratory Journal.
[16] A. Prasse,et al. Phenotyping sarcoidosis from a pulmonary perspective. , 2008, American journal of respiratory and critical care medicine.
[17] Christian Hennig,et al. Cluster-wise assessment of cluster stability , 2007, Comput. Stat. Data Anal..
[18] R. Elston,et al. Genetic linkage analysis of sarcoidosis phenotypes: the sarcoidosis genetic analysis (SAGA) study , 2007, Genes and Immunity.
[19] D. Anantham,et al. Sarcoidosis in Singapore: Epidemiology, clinical presentation and ethnic differences , 2007, Respirology.
[20] M. Yigla,et al. Sarcoidosis in residents of northern Israel of Arabic and Jewish origin: a comparative study , 2006, Respirology.
[21] R. Elston,et al. Comparison of sarcoidosis phenotypes among affected African-American siblings. , 2006, Chest.
[22] Michael Krawczak,et al. PopGen: Population-Based Recruitment of Patients and Controls for the Analysis of Complex Genotype-Phenotype Relationships , 2006, Public Health Genomics.
[23] Milton D. Rossman,et al. COMPLICATIONS OF VIDEO ASSISTED THORACOSCOPIC LUNG BIOPSY IN PATIENTS WITH INTERSTITIAL LUNG DISEASE , 2005 .
[24] D. Lackland,et al. Relationship of environmental exposures to the clinical phenotype of sarcoidosis. , 2005, Chest.
[25] C. Rand,et al. The diagnostic pathway to sarcoidosis. , 2003, Chest.
[26] M. Judson. Hepatic, Splenic, and Gastrointestinal Involvement with Sarcoidosis , 2002, Seminars in respiratory and critical care medicine.
[27] G. McLennan,et al. Clinical characteristics of patients in a case control study of sarcoidosis. , 2001, American journal of respiratory and critical care medicine.
[28] G. Hillerdal,et al. Increased risk for cancer following sarcoidosis. , 1999, American journal of respiratory and critical care medicine.
[29] D. Lackland,et al. Geographic variation in sarcoidosis in South Carolina: its relation to socioeconomic status and health care indicators. , 1999, American journal of epidemiology.
[30] R. Baughman,et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis. , 1999, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[31] R. Loddenkemper,et al. Clinical findings in 715 patients with newly detected pulmonary sarcoidosis--results of a cooperative study in former West Germany and Switzerland. WATL Study Group. Wissenschaftliche Arbeitsgemeinschaft für die Therapie von Lungenkrankheitan. , 1998, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[32] M. Yamaguchi,et al. Global epidemiology of sarcoidosis. What story do prevalence and incidence tell us? , 1997, Clinics in chest medicine.
[33] D. Palli,et al. A population-based study of inflammatory bowel disease in Florence over 15 years (1978-92). , 1996, Scandinavian journal of gastroenterology.
[34] M. Ohmichi,et al. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. , 1996, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.
[35] J. Stocks,et al. Reference values for residual volume, functional residual capacity and total lung capacity. ATS Workshop on Lung Volume Measurements. Official Statement of The European Respiratory Society. , 1995, The European respiratory journal.
[36] J E Cotes,et al. Lung volumes and forced ventilatory flows , 1993, European Respiratory Journal.
[37] J E Cotes,et al. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. , 1993, The European respiratory journal. Supplement.
[38] L. Elveback,et al. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. , 1986, American journal of epidemiology.
[39] D. James,et al. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. , 1983, The Quarterly journal of medicine.
[40] W. Roberts,et al. Sarcoidosis of the heart: A clinicopathologic study of 35 necropsy patients (group I) and review of 78 previously described necropsy patients (group II) , 1977 .
[41] J. Scadding. Prognosis of Intrathoracic Sarcoidosis in England , 1961, British medical journal.
[42] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[43] Julie Josse,et al. Principal component methods - hierarchical clustering - partitional clustering: why would we need to choose for visualizing data? , 2010 .
[44] H. Reynolds,et al. Sarcoidosis: Impact of Other Illnesses on the Presentation and Management of Multi-Organ Disease , 2002, Lung.
[45] Consensus conference: activity of sarcoidosis. Third WASOG meeting, Los Angeles, USA, September 8-11, 1993. , 1994, The European respiratory journal.